Table 2 Participants’ demographic information and results of a subset of clinical outcomes measures
Participant ID | Group | Age | Gender | SOT | Mini-BESTest28 | 5xSST duration (s) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pre | Mid | Post | Pre | Mid | Post | Pre | Mid | Post | ||||
1 | CG | 83 | M | 71 | 81 | 81 | 21 | 22 | 25 | 11.0 | 12.5 | 14.6 |
2 | EG | 83 | F | 63 | 72 | 83 | 22 | 24 | 25 | 12.0 | 10.3 | 11.0 |
3 | EG | 70 | F | 78 | 81 | 76 | 20 | 26 | 27 | 10.1 | 9.7 | 8.7 |
4 | CG | 72 | F | 49 | 45 | 46 | 25 | 25 | 24 | 7.4 | 9.3 | 11.0 |
5 | CG | 70 | M | 76 | 79 | 73 | 26 | 27 | 22 | 9.7 | 8.4 | 11.4 |
6 | EG | 80 | M | 68 | 72 | 86 | 23 | 24 | 23 | 14.7 | 13.6 | 12.3 |
7 | CG | 73 | M | 60 | 68 | 65 | 24 | 25 | 25 | 8.8 | 10.0 | 8.3 |
8 | EG | 70 | F | 83 | 86 | 85 | 24 | 28 | 27 | 12.2 | 8.4 | 6.6 |
9 | EG | 82 | F | 74 | 78 | 79 | 25 | 25 | 26 | 17.8 | 14.2 | 15.0 |
10 | CG | 78 | F | 83 | 84 | 85 | 23 | 22 | 25 | 13.7 | 9.7 | 9.9 |
11 | CG | 74 | F | 68 | 77 | 76 | 24 | 24 | 24 | 17.7 | 9.7 | 9.5 |
12 | EG | 74 | F | 50 | 73 | 79 | 19 | 26 | 26 | 14.6 | 11.1 | 10.6 |